Phytoestrogens and their putative effects on the aryl hydrocarbon receptor

Current Bioactive Compounds

Volumn 7, Issue 3, 2011, Pages 136-155

  Medjakovic, Svjetlana ^a,b   Jungbauer, Alois ^a,b  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b INSTITUTE FOR MICROELECTRONICS   (Austria)

Author keywords

Aryl hydrocarbon receptor; Cell cycle; Estrogen receptor; Indoles; Isoflavones; Phytoestrogens; Xenobiotic metabolism

Indexed keywords

17 HYDROXYPREGNENOLONE; 3 INDOLEMETHANOL; ANDROSTENEDIONE; AROMATIC HYDROCARBON RECEPTOR; BIOCHANIN A; CHALCONE DERIVATIVE; CHOLESTEROL; COUMESTAN DERIVATIVE; DAIDZEIN; DIINDOLYLMETHANE; ESTROGEN RECEPTOR; FLAVONOID; FORMONONETIN; GENISTEIN; GLYCITEIN; HYDROXYPROGESTERONE; INDOLE DERIVATIVE; INDOLO[3,2 B]CARBAZOLE; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHENOL DERIVATIVE; PHYTOESTROGEN; PHYTOSTEROL; POLYPHENOL DERIVATIVE; PRASTERONE SULFATE; PREGNENOLONE; PROGESTERONE; SITOSTEROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CELL CYCLE REGULATION; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG STRUCTURE; ESTROGEN ACTIVITY; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

EID: 80051715729     PISSN: 15734072     EISSN: 18756646     Source Type: Journal    
DOI: 10.2174/157340711796817922     Document Type: Article

References (336)

1. Pollenz, R. S.; Sattler, C. A.; Poland, A. The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. Mol. Pharmacol., 1994, 45 (3), 428-438.
2. Berg, P.; Pongratz, I. Two parallel pathways mediate cytoplasmic localization of the dioxin (aryl hydrocarbon) receptor. J. Biol. Chem., 2002, 277 (35), 32310-32319.
3. Kazlauskas, A.; Sundström, S.; Poellinger, L.; Pongratz, I. The hsp90 chaperone complex regulates intracellular localization of the dioxin receptor. Mol. Cell. Biol., 2001, 21 (7), 2594-2607.
4. Beischlag, T. V.; Luis Morales, J.; Hollingshead, B. D.; Perdew, G. H. The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene Expr., 2008, 18 (3), 207-250.
5. Mimura, J.; Ema, M.; Sogawa, K.; Fujii-Kuriyama, Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev., 1999, 13 (1), 20-25.
6. Haarmann-Stemmann, T.; Abel, J. The arylhydrocarbon receptor repressor (AhRR): structure, expression, and function. Biol. Chem., 2006, 387 (9), 1195-1199.
7. Baba, T.; Mimura, J.; Gradin, K.; Kuroiwa, A.; Watanabe, T.; Matsuda, Y.; Inazawa, J.; Sogawa, K.; Fujii-Kuriyama, Y. Structure and expression of the Ah receptor repressor gene. J. Biol. Chem., 2001, 276 (35), 33101-33110.
8. Watanabe, T.; Imoto, I.; Kosugi, Y.; Fukuda, Y.; Mimura, J.; ujii, Y.; Isaka, K.; Takayama, M.; Sato, A.; Inazawa, J. Human arylhydrocarbon receptor repressor (AHRR) gene: genomic structure and analysis of polymorphism in endometriosis. J. Hum. Genet., 2001, 46 (6), 342-346.
9. Korkalainen, M.; Tuomisto, J.; Pohjanvirta, R. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain. Biochem. Biophys. Res. Commun., 2004, 315 (1), 123-131.
10. Evans, B. R.; Karchner, S. I.; Franks, D. G.; Hahn, M. E. Duplicate aryl hydrocarbon receptor repressor genes (ahrr1 and ahrr2) in the zebrafish Danio rerio: structure, function, evolution, and AHRdependent regulation in vivo. Arch. Biochem. Biophys., 2005, 441 (2), 151-167.
11. Evans, B. R.; Karchner, S. I.; Allan, L. L.; Pollenz, R. S.; Tanguay, R. L.; Jenny, M. J.; Sherr, D. H.; Hahn, M. E. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol. Pharmacol., 2008, 73 (2), 387-398.
12. Hahn, M. E.; Allan, L. L.; Sherr, D. H. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem. Pharmacol., 2009, 77 (4), 485-497.
13. Kewley, R. J.; Whitelaw, M. L.; Chapman-Smith, A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol., 2004, 36 (2), 189-204.
14. Robinson-Rechavi, M.; Escriva, G. H.; Laudet, V. The nuclear receptor superfamily. J. Cell Sci., 2003, 116 (Pt 4), 585-586.
15. Chang, J. T.; Chang, H.; Chen, P. H.; Lin, S. L.; Lin, P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up regulation and cell growth in human lung adenocarcinomas. Clin. Cancer Res., 2007, 13 (1), 38-45.
16. Koliopanos, A.; Kleeff, J.; Xiao, Y.; Safe, S.; Zimmermann, A.; Büchler, M. W.; Friess, H. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer. Oncogene, 2002, 21 (39), 6059-6070.
17. Lin, P.; Chang, H.; Tsai, W. T.; Wu, M. H.; Liao, Y. S.; Chen, J. T.; Su, J. M. Overexpression of aryl hydrocarbon receptor in human lung carcinomas. Toxicol. Pathol., 2003, 31 (1), 22-30.
18. Peng, T. L.; Chen, J.; Mao, W.; Liu, X.; Tao, Y.; Chen, L. Z.; Chen, M. H. Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer. World J. Gastroenterol., 2009, 15 (14), 1719-1729.
19. Wong, P. S.; Li, W.; Vogel, C. F.; Matsumura, F. Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR). BMC Cancer, 2009, 9, 234.
20. Saeki, K. I.; Kato, T. A.; Yamada, K.; Mizutani, T.; Miyata, N.; Matsuda, T.; Matsui, S.; Fukuhara, K. Activation of the human Ah receptor by aza-polycyclic aromatic hydrocarbons and their halogenated derivatives. Biol. Pharm. Bull., 2003, 26 (4), 448-452.
21. Chen, G.; Bunce, N. J. Interaction between halogenated aromatic compounds in the Ah receptor signal transduction pathway. Environ. Toxicol., 2004, 19 (5), 480-489.
22. Abnet, C. C.; Tanguay, R. L.; Heideman, W.; Peterson, R. E. Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol. Appl. Pharmacol., 1999, 159 (1), 41-51.
23. De Waard, W. J.; Aarts, J. M.; Peijnenburg, A. C.; De Kok, T. M.; Van Schooten, F. J.; Hoogenboom, L. A. Ah receptor agonist activity in frequently consumed food items. Food Addit. Contam. Part A Chem. Anal. Control Expo Risk Assess, 2008, 25 (6), 779-787.
24. Amakura, Y.; Tsutsumi, T.; Sasaki, K.; Maitani, T.; Nakamura, M.; Kitagawa, H.; Fujino, J.; Toyoda, M.; Yoshida, T. Activation of the aryl hydrocarbon receptor by some vegetable constituents determined using in vitro reporter gene assay. Biol. Pharm. Bull., 2003, 26 (4), 532-539.
25. Amakura, Y.; Tsutsumi, T.; Sasaki, K.; Maitani, T.; Yoshida, T. Screening of the inhibitory effect of vegetable constituents on the aryl hydrocarbon receptor-mediated activity induced by 2,3,7,8- tetrachlorodibenzo-p- dioxin. Biol. Pharm. Bull., 2003, 26 (12), 1754-1760.
26. Fukuda, I.; Mukai, R.; Kawase, M.; Yoshida, K.; Ashida, H. Interaction between the aryl hydrocarbon receptor and its antagonists, flavonoids. Biochem. Biophys. Res. Commun., 2007, 359 (3), 822-827.
27. Pohl, C.; Will, F.; Dietrich, H.; Schrenk, D. Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols. J. Agric. Food Chem., 2006, 54 (26), 10262-10268.
28. Medjakovic, S.; Jungbauer, A. Red clover isoflavones biochanin A and formononetin are potent ligands of the human aryl hydrocarbon receptor. J. Steroid Biochem. Mol. Biol., 2008, 108 (1-2), 171-177.
29. Haarmann-Stemmann, T.; Sendker, J.; Gotz, C.; Krug, N.; Bothe, H.; Fritsche, E.; Proksch, P.; Abel, J. Regulation of dioxin receptor function by different beta-carboline alkaloids. Arch. Toxicol., 2010, 84 (8), 619-629.
30. Hayes, J. D.; Kelleher, M. O.; Eggleston, I. M. The cancer chemopreventive actions of phytochemicals derived from glucosinolates, Eur. J. Nutr., 2008, 47 (Suppl 2), 73-88.
31. de Waard, P. W.; Peijnenburg, A. A.; Baykus, H.; Aarts, J. M.; Hoogenboom, R. L.; van Schooten, F. J.; de Kok, T. M. A human intervention study with foods containing natural Ah-receptor agonists does not significantly show AhR-mediated effects as measured in blood cells and urine. Chem. Biol. Interact., 2008, 176 (1), 19-29.
32. Bohn, S. K.; Myhrstad, M. C.; Thoresen, M.; Holden, M.; Karlsen, A.; Tunheim, S. H.; Erlund, I.; Svendsen, M.; Seljeflot, I.; Moskaug, J. O.; Duttaroy, A. K.; Laake, P.; Arnesen, H.; Tonstad, S.; Collins, A.; Drevon, C. A.; Blomhoff, R. Blood cell gene expression associated with cellular stress defense is modulated by antioxidant- rich food in a randomised controlled clinical trial of male smokers. BMC Med., 2010, 8, 54.
33. Grose, K. R.; Bjeldanes, L. F. Oligomerization of indole-3-carbinol in aqueous acid. Chem. Res. Toxicol., 1992, 5 (2), 188.
34. Bjeldanes, L. F.; Kim, J. Y.; Grose, K. R.; Bartholomew, J. C.; Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: Comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl. Acad. Sci. USA, 1991, 88 (21), 9543-9547.
35. Wortelboer, H. M.; van der Linden, E. C.; de Kruif, C. A.; Noordhoek, J.; Blaauboer, B. J.; van Bladeren, P. J.; Falke, H. E. Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures. Food Chem. Toxicol., 1992, 30 (7), 589-599.
36. Anderton, M. J.; Manson, M. M.; Verschoyle, R. D.; Gescher, A.; Lamb, J. H.; Farmer, P. B.; Steward, W. P.; Williams, M. L. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin. Cancer Res., 2004, 10 (15), 5233-5241.
37. Reed, G. A.; Arneson, D. W.; Putnam, W. C.; Smith, H. J.; Gray, J. C.; Sullivan, D. K.; Mayo, M. S.; Crowell, J. A.; Hurwitz, A. Single- dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane. Cancer Epidemiol. Biomarkers Prev., 2006, 15 (12), 2477-2481.
38. Bradlow, H. L.; Zeligs, M. A. Diindolylmethane (DIM) spontaneously forms from Indole-3-carbinol (I3C) during cell culture experiments. In Vivo, 2010, 24 (4), 387-391.
39. Staub, R. E.; Feng, C.; Onisko, B.; Bailey, G. S.; Firestone, G. L.; Bjeldanes, L. F. Fate of indole-3-carbinol in cultured human breast tumor cells. Chem. Res. Toxicol., 2002, 15 (2), 101-109.
40. Kwon, C. S.; Grose, K. R.; Riby, J.; Chen, Y. H.; Bjeldanes, L. F. In vivo production and enzyme-inducing activity of indolo[3,2- b]carbazole. J. Agric. Food Chem., 1994, 42 (11), 2536-2540.
41. Gillner, M.; Bergman, J.; Cambillau, C.; Alexandersson, M.; Fernstrom, B.; Gustafsson, J. A. Interactions of indolo[3,2-b]carbazoles and related polycyclic aromatic hydrocarbons with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol. Pharmacol., 1993, 44 (2), 336-345.
42. Chen, Y. H.; Riby, J.; Srivastava, P.; Bartholomew, J.; Denison, M.; Bjeldanes, L. Regulation of CYP1A1 by indolo[3,2- b]carbazole in murine hepatoma cells. J. Biol. Chem., 1995, 270 (38), 22548-22555.
43. Jellinck, P. H.; Forkert, P. G.; Riddick, D. S.; Okey, A. B.; Michnovicz, J. J.; Bradlow, H. L. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem. Pharmacol., 1993, 45 (5), 1129-1136.
44. Miller Iii, C. A. Expression of the human aryl hydrocarbon receptor complex in yeast. Activation of transcription by indole compounds. J. Biol. Chem., 1997, 272 (52), 32824-32829.
45. Chen, I.; Safe, S.; Bjeldanes, L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol., 1996, 51 (8), 1069-1076.
46. Liu, H.; Wormke, M.; Safe, S. H.; Bjeldanes, L. F. Indolo[3,2- b]carbazole: A dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J. Natl. Cancer Inst., 1994, 86 (23), 1758-1765.
47. Bovee, T. F.; Schoonen, W. G.; Hamers, A. R.; Bento, M. J.; Peijnenburg, A. A. Screening of synthetic and plant-derived compounds for (anti)estrogenic and (anti)androgenic activities. Anal. Bioanal. Chem., 2008, 390 (4), 1111-1119.
48. Liu, S.; Abdelrahim, M.; Khan, S.; Ariazi, E.; Jordan, V. C.; Safe, S. Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cells. Biol. Chem., 2006, 387 (9), 1209-1213.
49. Yuan, F.; Chen, D. Z.; Liu, K.; Sepkovic, D. W.; Bradlow, H. L.; Auborn, K. Anti-estrogenic activities of indole-3-carbinol in cervical cells: implication for prevention of cervical cancer. Anticancer Res., 1999, 19 (3A), 1673-1680.
50. Chang, Y. C.; Riby, J.; Chang, G. H.; Peng, B. C.; Firestone, G.; Bjeldanes, L. F. Cytostatic and antiestrogenic effects of 2-(indol-3- ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem. Pharmacol., 1999, 58 (5), 825-834.
51. Riby, J. E.; Feng, C.; Chang, Y. C.; Schaldach, C. M.; Firestone, G. L.; Bjeldanes, L. F. The major cyclic trimeric product of indole-3- carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochemistry (Mosc.), 2000, 39 (5), 910-918.
52. Xue, L.; Schaldach, C. M.; Janosik, T.; Bergman, J.; Bjeldanes, L. F. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells. Chem. Biol. Interact., 2005, 152 (2-3), 119-129.
53. Mulvey, L.; Chandrasekaran, A.; Liu, K.; Lombardi, S.; Wang, X. P.; Auborn, K. J.; Goodwin, L. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines. Mol. Med., 2007, 13 (1-2), 69-78.
54. Meng, Q.; Yuan, F.; Goldberg, I. D.; Rosen, E. M.; Auborn, K.; Fan, S. Indole-3-carbinol is a negative regulator of estrogen receptor-α signaling in human tumor cells. J. Nutr., 2000, 130 (12), 2927-2931.
55. Chen, I.; McDougal, A.; Wang, F.; Safe, S. Aryl hydrocarbon receptor- mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis, 1998, 19 (9), 1631-1639.
56. Gao, X.; Petroff, B. K.; Oluola, O.; Georg, G.; Terranova, P. F.; Rozman, K. K. Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation. Toxicol. Appl. Pharmacol., 2002, 183 (3), 179-188.
57. Vivar, O. I.; Saunier, E. F.; Leitman, D. C.; Firestone, G. L.; Bjeldanes, L. F. Selective activation of estrogen receptor-beta target genes by 3,3'-diindolylmethane. Endocrinology, 2010, 151 (4), 1662-1667.
58. Sundar, S. N.; Kerekatte, V.; Equinozio, C. N.; Doan, V. B.; Bjeldanes, L. F.; Firestone, G. L. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells. Mol. Endocrinol., 2006, 20 (12), 3070-3082.
59. Leong, H.; Riby, J. E.; Bjeldanes, L. F.; Firestone, G. L. Potent ligand-independent estrogen receptor activation by 3,3'- diindolylmethane is mediated by cross talk between the protein kinase a and mitogen-activated protein kinase signaling pathways. Mol. Endocrinol., 2004, 18 (2), 291-302.
60. Riby, J. E.; Chang, G. H.; Firestone, G. L.; Bjeldanes, L. F. Ligandindependent activation of estrogen receptor function by 3, 3'- diindolylmethane in human breast cancer cells. Biochem. Pharmacol., 2000, 60 (2), 167-177.
61. Marconett, C. N.; Sundar, S. N.; Poindexter, K. M.; Stueve, T. R.; Bjeldanes, L. F.; Firestone, G. L. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha- GATA3 transcriptional cross-regulatory loop. Mol. Biol. Cell, 2010, 21 (7), 1166-1177.
62. Wang, T. T.; Milner, M. J.; Milner, J. A.; Kim, Y. S. Estrogen receptor alpha as a target for indole-3-carbinol. J. Nutr. Biochem., 2006, 17 (10), 659-664.
63. Medjakovic, S.; Mueller, M.; Jungbauer, A. Potential healthmodulating effects of isoflavones and metabolites via activation of PPAR and AhR. Nutrients, 2010, 2, 241-279.
64. Ashida, H.; Fukuda, I.; Yamashita, T.; Kanazawa, K. Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin. FEBS Lett., 2000, 476 (3), 213-217.
65. Zhang, S.; Qin, C.; Safe, S. H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ. Health Perspect., 2003, 111 (16), 1877-1882.
66. Hamada, M.; Satsu, H.; Natsume, Y.; Nishiumi, S.; Fukuda, I.; Ashida, H.; Shimizu, M. TCDD-induced CYP1A1 expression, an index of dioxin toxicity, is suppressed by flavonoids permeating the human intestinal Caco-2 cell monolayers. J. Agric. Food Chem., 2006, 54 (23), 8891-8898.
67. Shertzer, H. G.; Puga, A.; Chang, C.; Smith, P.; Nebert, D. W.; Setchell, K. D.; Dalton, T. P. Inhibition of CYP1A1 enzyme activity in mouse hepatoma cell culture by soybean isoflavones. Chem. Biol. Interact., 1999, 123 (1), 31-49.
68. Chan, H. Y.; Wang, H.; Leung, L. K. The red clover (Trifolium pratense) isoflavone biochanin A modulates the biotransformation pathways of 7,12-dimethylbenz[a]anthracene. Br. J. Nutr., 2003, 90 (1), 87-92.
69. Han, E. H.; Ji, Y. K.; Hye, G. J. Effect of biochanin A on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Arch. Pharm. Res., 2006, 29 (7), 570-576.
70. Hahn, M. E.; Karchner, S. I.; Shapiro, M. A.; Perera, S. A. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc. Natl. Acad. Sci. USA, 1997, 94 (25), 13743-13748.
71. Karchner, S. I.; Franks, D. G.; Powell, W. H.; Hahn, M. E. Regulatory interactions among three members of the vertebrate aryl hydrocarbon receptor family: AHR repressor, AHR1, and AHR2. J. Biol. Chem., 2002, 277 (9), 6949-6959.
72. Zhou, H.; Qu, Y.; Wu, H.; Liao, C.; Zheng, J.; Diao, X.; Xue, Q. Molecular phylogenies and evolutionary behavior of AhR (aryl hydrocarbon receptor) pathway genes in aquatic animals: implications for the toxicology mechanism of some persistent organic pollutants (POPs). Chemosphere, 2010, 78 (2), 193-205.
73. Tijet, N.; Boutros, P. C.; Moffat, I. D.; Okey, A. B.; Tuomisto, J.; Pohjanvirta, R. Aryl hydrocarbon receptor regulates distinct dioxindependent and dioxin-independent gene batteries. Mol. Pharmacol., 2006, 69 (1), 140-153.
74. Yoon, C. Y.; Park, M.; Kim, B. H.; Park, J. Y.; Park, M. S.; Jeong, Y. K.; Kwon, H.; Jung, H. K.; Kang, H.; Lee, Y. S.; Lee, B. J. Gene expression profile by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the liver of wild-type (AhR+/+) and aryl hydrocarbon receptordeficient (AhR-/-) mice. J. Vet. Med. Sci., 2006, 68 (7), 663-668.
75. Abbott, B. D.; Birnbaum, L. S.; Perdew, G. H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev. Dyn., 1995, 204 (2), 133-143.
76. Roman, A. C.; Carvajal-Gonzalez, J. M.; Rico-Leo, E. M.; Fernandez- Salguero, P. M. Dioxin receptor deficiency impairs angiogenesis by a mechanism involving VEGF-A depletion in the endothelium and transforming growth factor-beta overexpression in the stroma. J. Biol. Chem., 2009, 284 (37), 25135-25148.
77. Takeuchi, A.; Takeuchi, M.; Oikawa, K.; Sonoda, K. H.; Usui, Y.; Okunuki, Y.; Takeda, A.; Oshima, Y.; Yoshida, K.; Usui, M.; Goto, H.; Kuroda, M. Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization. Invest. Ophthalmol. Vis. Sci., 2009, 50 (7), 3410-3416.
78. Fritz, W. A.; Lin, T. M.; Peterson, R. E. The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Carcinogenesis, 2008, 29 (5), 1077-1082.
79. Fritz, W. A.; Lin, T. M.; Safe, S.; Moore, R. W.; Peterson, R. E. The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8- trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice. Biochem. Pharmacol., 2009, 77 (7), 1151-1160.
80. Kawamura, T.; Yamashita, I. Aryl hydrocarbon receptor is required for prevention of blood clotting and for the development of vasculature and bone in the embryos of medaka fish, Oryzias latipes. Zoolog. Sci., 2002, 19 (3), 309-319.
81. Hayashida, Y.; Kawamura, T.; Hori-e, R.; Yamashita, I. Retionic acid and its receptors are required for expression of aryl hydrocarbon receptor mRNA and embryonic development of blood vessel and bone in the medaka fish, Oryzias latipes. Zoolog. Sci., 2004, 21 (5), 541-551.
82. Lahvis, G. P.; Pyzalski, R. W.; Glover, E.; Pitot, H. C.; McElwee, M. K.; Bradfield, C. A. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol., 2005, 67 (3), 714-720.
83. Walisser, J. A.; Bunger, M. K.; Glover, E.; Bradfield, C. A. Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development. Proc. Natl. Acad. Sci. USA, 2004, 101 (47), 16677-16682.
84. Kerger, B. D.; Leung, H. W.; Scott, P.; Paustenbach, D. J.; Needham, L. L.; Patterson, D. G., Jr.; Gerthoux, P. M.; Mocarelli, P. Age- and concentration-dependent elimination half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Seveso children. Environ. Health Perspect., 2006, 114 (10), 1596-1602.
85. Miniero, R.; De Felip, E.; Ferri, F.; di Domenico, A. An overview of TCDD half-life in mammals and its correlation to body weight. Chemosphere, 2001, 43 (4-7), 839-844.
86. Ishimura, R.; Kawakami, T.; Ohsako, S.; Nohara, K.; Tohyama, C. Suppressive effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vascular remodeling that takes place in the normal labyrinth zone of rat placenta during late gestation. Toxicol. Sci., 2006, 91 (1), 265-274.
87. Ishimura, R.; Ohsako, S.; Kawakami, T.; Sakaue, M.; Aoki, Y.; Tohyama, C. Altered protein profile and possible hypoxia in the placenta of 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed rats. Toxicol. Appl. Pharmacol., 2002, 185 (3), 197-206.
88. Korenaga, T.; Fukusato, T.; Ohta, M.; Asaoka, K.; Murata, N.; Arima, A.; Kubota, S. Long-term effects of subcutaneously injected 2,3,7,8-tetrachlorodibenzo-p-dioxin on the liver of rhesus monkeys. Chemosphere, 2007, 67 (9), S399-404.
89. Tauchi, M.; Hida, A.; Negishi, T.; Katsuoka, F.; Noda, S.; Mimura, J.; Hosoya, T.; Yanaka, A.; Aburatani, H.; Fujii-Kuriyama, Y.; Motohashi, H.; Yamamoto, M. Constitutive expression of aryl hydrocarbon receptor in keratinocytes causes inflammatory skin lesions. Mol. Cell. Biol., 2005, 25 (21), 9360-9368.
90. Hogaboam, J. P.; Moore, A. J.; Lawrence, B. P. The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicol. Sci., 2008, 102 (1), 160-170.
91. Mitchell, K. A.; Lockhart, C. A.; Huang, G.; Elferink, C. J. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol. Pharmacol., 2006, 70 (1), 163-170.
92. Andersson, P.; McGuire, J.; Rubio, C.; Gradin, K.; Whitelaw, M. L.; Pettersson, S.; Hanberg, A.; Poellinger, L. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors, Proc. Natl. Acad. Sci. USA, 2002, 99 (15), 9990-9995.
93. Kuznetsov, N. V.; Andersson, P.; Gradin, K.; Stein, P.; Dieckmann, A.; Pettersson, S.; Hanberg, A.; Poellinger, L. The dioxin/aryl hydrocarbon receptor mediates down regulation of osteopontin gene expression in a mouse model of gastric tumourigenesis. Oncogene, 2005, 24 (19), 3216-3222.
94. Moennikes, O.; Loeppen, S.; Buchmann, A.; Andersson, P.; Ittrich, C.; Poellinger, L.; Schwarz, M. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res., 2004, 64 (14), 4707-4710.
95. Gasiewicz, T. A.; Singh, K. P.; Casado, F. L. The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: implications for benzene-induced hematopoietic toxicity. Chem. Biol. Interact., 2010, 184 (1-2), 246-251.
96. Marshall, N. B.; Kerkvliet, N. I. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann. N. Y. Acad. Sci., 2010, 1183, 25-37.
97. Esser, C.; Rannug, A.; Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol., 2009, 30 (9), 447-454.
98. Rannug, A.; Fritsche, E. The aryl hydrocarbon receptor and light. Biol. Chem., 2006, 387 (9), 1149-1157.
99. Bradshaw, T. D.; Bell, D. R. Relevance of the aryl hydrocarbon receptor (AhR) for clinical toxicology. Clin Toxicol (Phila), 2009, 47 (7), 632-642.
100. Singh, K. P.; Casado, F. L.; Opanashuk, L. A.; Gasiewicz, T. A. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem. Pharmacol., 2009, 77 (4), 577-587.
101. Ikuta, T.; Namiki, T.; Fujii-Kuriyama, Y.; Kawajiri, K. AhR protein trafficking and function in the skin. Biochem. Pharmacol., 2009, 77 (4), 588-596.
102. Baba, T.; Mimura, J.; Nakamura, N.; Harada, N.; Yamamoto, M.; Morohashi, K. I.; Fujii-Kuriyama, Y. Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. Mol. Cell. Biol., 2005, 25 (22), 10040-10051.
103. Hernandez-Ochoa, I.; Karman, B. N.; Flaws, J. A. The role of the aryl hydrocarbon receptor in the female reproductive system. Biochem. Pharmacol., 2009, 77 (4), 547-559.
104. Kung, T.; Murphy, K. A.; White, L. A. The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochem. Pharmacol., 2009, 77 (4), 536-546.
105. Nebert, D. W.; Karp, C. L. Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J. Biol. Chem., 2008, 283 (52), 36061-36065.
106. Nebert, D. W.; Petersen, D. D.; Fornace, A. J., Jr. Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. Environ. Health Perspect., 1990, 88 13-25.
107. Rivera, S. P.; Wang, F.; Saarikoski, S. T.; Taylor, R. T.; Chapman, B.; Zhang, R.; Hankinson, O. A novel promoter element containing multiple overlapping xenobiotic and hypoxia response elements mediates induction of cytochrome P4502S1 by both dioxin and hypoxia. J. Biol. Chem., 2007, 282 (15), 10881-10893.
108. Brauze, D.; Widerak, M.; Cwykiel, J.; Szyfter, K.; Baer-Dubowska, W. The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver. Toxicol. Lett., 2006, 167 (3), 212-220.
109. Mizutani, T.; Yoshino, M.; Satake, T.; Nakagawa, M.; Ishimura, R.; Tohyama, C.; Kokame, K.; Kangawa, K.; Miyamoto, K. Identification of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible and -suppressive genes in the rat placenta: induction of interferonregulated genes with possible inhibitory roles for angiogenesis in the placenta. Endocr. J., 2004, 51 (6), 569-577.
110. Sinal, C. J.; Webb, C. D.; Bend, J. R. Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney. J. Biochem. Mol. Toxicol., 1999, 13 (1), 29-40.
111. Boutros, P. C.; Bielefeld, K. A.; Pohjanvirta, R.; Harper, P. A. Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol. Sci., 2009, 112 (1), 245-256.
112. Aluru, N.; Vijayan, M. M. Brain transcriptomics in response to beta-naphthoflavone treatment in rainbow trout: the role of aryl hydrocarbon receptor signaling. Aquat. Toxicol., 2008, 87 (1), 1-12.
113. Deb, S.; Bandiera, S. M. Characterization of a new cytochrome P450 enzyme, CYP2S1, in rats: its regulation by aryl hydrocarbon receptor agonists. Toxicology, 2010, 267 (1-3), 91-98.
114. Volotinen, M.; Maenpaa, J.; Kankuri, E.; Oksala, O.; Pelkonen, O.; Nakajima, M.; Yokoi, T.; Hakkola, J. Expression of cytochrome P450 (CYP) enzymes in human nonpigmented ciliary epithelial cells: induction of CYP1B1 expression by TCDD. Invest. Ophthalmol. Vis. Sci., 2009, 50 (7), 3099-3105.
115. Schaufler, K.; Haslmayer, P.; Jager, W.; Pec, M.; Thalhammer, T. The environmental toxin 2,3,7,8-tetrachlorodibenzo-p-dioxin induces cytochrome P450 activity in high passage PC 3 and DU 145 human prostate cancer cell lines. Int. J. Mol. Med., 2002, 9 (4), 411-416.
116. Tang, N. J.; Liu, J.; Coenraads, P. J.; Dong, L.; Zhao, L. J.; Ma, S. W.; Chen, X.; Zhang, C. M.; Ma, X. M.; Wei, W. G.; Zhang, P.; Bai, Z. P. Expression of AhR, CYP1A1, GSTA1, c-fos and TGFalpha in skin lesions from dioxin-exposed humans with chloracne. Toxicol. Lett., 2008, 177 (3), 182-187.
117. McHale, C. M.; Zhang, L.; Hubbard, A. E.; Zhao, X.; Baccarelli, A.; Pesatori, A. C.; Smith, M. T.; Landi, M. T. Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin- exposed human subjects. Toxicology, 2007, 229 (1-2), 101-113.
118. Di Bello, D.; Vaccaro, E.; Longo, V.; Regoli, F.; Nigro, M.; Benedetti, M.; Gervasi, P. G.; Pretti, C. Presence and inducibility by beta-naphthoflavone of CYP1A1, CYP1B1 and phase II enzymes in Trematomus bernacchii, an Antarctic fish. Aquat. Toxicol., 2007, 84 (1), 19-26.
119. Karyala, S.; Guo, J.; Sartor, M.; Medvedovic, M.; Kann, S.; Puga, A.; Ryan, P.; Tomlinson, C. R. Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice. Cardiovasc. Toxicol., 2004, 4 (1), 47-73.
120. Yueh, M. F.; Huang, Y. H.; Hiller, A.; Chen, S.; Nguyen, N.; Tukey, R. H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDPglucuronosyltransferase 1A1. J. Biol. Chem., 2003, 278 (17), 15001-15006.
121. Wu, Q.; Suzuki, J. S.; Zaha, H.; Lin, T. M.; Peterson, R. E.; Tohyama, C.; Ohsako, S. Differences in gene expression and benzo[a]pyrene-induced DNA adduct formation in the liver of three strains of female mice with identical AhRb2 genotype treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and/or benzo[a]pyrene. J. Appl. Toxicol., 2008, 28 (6), 724-733.
122. Dey, A.; Jones, J. E.; Nebert, D. W. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem. Pharmacol., 1999, 58 (3), 525-537.
123. Shimada, T.; Sugie, A.; Shindo, M.; Nakajima, T.; Azuma, E.; Hashimoto, M.; Inoue, K. Tissue-specific induction of cytochromes P450 1A1 and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in engineered C57BL/6J mice of arylhydrocarbon receptor gene. Toxicol. Appl. Pharmacol., 2003, 187 (1), 1-10.
124. Nannelli, A.; Rossignolo, F.; Tolando, R.; Rossato, P.; Longo, V.; Gervasi, P. G. Effect of beta-naphthoflavone on AhR-regulated genes (CYP1A1, 1A2, 1B1, 2S1, Nrf2, and GST) and antioxidant enzymes in various brain regions of pig. Toxicology, 2009, 265 (3), 69-79.
125. Choi, E. J.; Kim, T. Daidzein modulates induction of hepatic CYP1A1, 1B1, and AhR by 7,12-dimethylbenz[a]anthracene in mice. Arch. Pharm. Res., 2008, 31 (9), 1115-1119.
126. Leung, H. Y.; Yung, L. H.; Poon, C. H.; Shi, G.; Lu, A. L.; Leung, L. K. Genistein protects against polycyclic aromatic hydrocarboninduced oxidative DNA damage in non-cancerous breast cells MCF-10A. Br. J. Nutr., 2009, 101 (2), 257-262.
127. Wagner, J.; Jiang, L.; Lehmann, L. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells Adv. Exp. Med. Biol., 2008, 617 625-632.
128. Shon, Y. H.; Park, S. D.; Nam, K. S. Effective chemopreventive activity of genistein against human breast cancer cells. J. Biochem. Mol. Biol., 2006, 39 (4), 448-451.
129. Kishida, T.; Nagamoto, M.; Ohtsu, Y.; Watakabe, M.; Ohshima, D.; Nashiki, K.; Mizushige, T.; Izumi, T.; Obata, A.; Ebihara, K. Lack of an inducible effect of dietary soy isoflavones on the mRNA abundance of hepatic cytochrome P-450 isozymes in rats. Biosci. Biotechnol. Biochem., 2004, 68 (3), 508-515.
130. Helsby, N. A.; Williams, J.; Kerr, D.; Gescher, A.; Chipman, J. K. The isoflavones equol and genistein do not induce xenobioticmetabolizing enzymes in mouse and in human cells. Xenobiotica, 1997, 27 (6), 587-596.
131. Scott, L. M.; Durant, P.; Leone-Kabler, S.; Wood, C. E.; Register, T. C.; Townsend, A.; Cline, J. M. Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes. J. Steroid Biochem. Mol. Biol., 2008, 112 (4-5), 179-185.
132. Mishra, P.; Kale, R. K.; Kar, A. Chemoprevention of mammary tumorigenesis and chemomodulation of the antioxidative enzymes and peroxidative damage in prepubertal Sprague Dawley rats by Biochanin A. Mol. Cell. Biochem., 2008, 312 (1-2), 1-9.
133. Steiner, C.; Peters, W. H.; Gallagher, E. P.; Magee, P.; Rowland, I.; Pool-Zobel, B. L. Genistein protects human mammary epithelial cells from benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide and 4- hydroxy-2-nonenal genotoxicity by modulating the glutathione/ glutathione S-transferase system. Carcinogenesis, 2007, 28 (3), 738-748.
134. Breinholt, V.; Lauridsen, S. T.; Dragsted, L. O. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica, 1999, 29 (12), 1227-1240.
135. Mishra, P.; Kar, A.; Kale, R. K. Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: the role of peroxidative damage and antioxidative enzymes. Mol. Cell. Biochem., 2009, 325 (1-2), 149-157.
136. Appelt, L. C.; Reicks, M. M. Soy induces phase II enzymes but does not inhibit dimethylbenz[a]anthracene-induced carcinogenesis in female rats. J. Nutr., 1999, 129 (10), 1820-1826.
137. Wiegand, H.; Wagner, A. E.; Boesch-Saadatmandi, C.; Kruse, H. P.; Kulling, S.; Rimbach, G. Effect of dietary genistein on Phase II and antioxidant enzymes in rat liver. Cancer Genomics Proteomics, 2009, 6 (2), 85-92.
138. Hayeshi, R.; Mutingwende, I.; Mavengere, W.; Masiyanise, V.; Mukanganyama, S. The inhibition of human glutathione Stransferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem. Toxicol., 2007, 45 (2), 286-295.
139. Aneja, R.; Upadhyaya, G.; Prakash, S.; Dass, S. K.; Chandra, R. Ameliorating effect of phytoestrogens on CCl4-induced oxidative stress in the livers of male Wistar rats. Artif. Cells. Blood Substit. Immobil. Biotechnol., 2005, 33 (2), 201-213.
140. Froyen, E. B.; Reeves, J. L.; Mitchell, A. E.; Steinberg, F. M. Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice. J. Med. Food, 2009, 12 (6), 1227-1237.
141. Ansell, P. J.; Espinosa-Nicholas, C.; Curran, E. M.; Judy, B. M.; Philips, B. J.; Hannink, M.; Lubahn, D. B. In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology, 2004, 145 (1), 311-317.
142. Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y.; Oyake, T.; Hayashi, N.; Satoh, K.; Hatayama, I.; Yamamoto, M.; Nabeshima, Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun., 1997, 236 (2), 313-322.
143. Shin, S.; Wakabayashi, N.; Misra, V.; Biswal, S.; Lee, G. H.; Agoston, E. S.; Yamamoto, M.; Kensler, T. W. NRF2 modulates aryl hydrocarbon receptor signaling: influence on adipogenesis. Mol. Cell. Biol., 2007, 27 (20), 7188-7197.
144. Miao, W.; Hu, L.; Scrivens, P. J.; Batist, G. Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes. J. Biol. Chem., 2005, 280 (21), 20340-20348.
145. Köhle, C.; Bock, K. W. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem. Pharmacol., 2007, 73 (12), 1853-1862.
146. Herrmann, S.; Seidelin, M.; Bisgaard, H. C.; Vang, O. Indolo[3,2- b]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter. Carcinogenesis, 2002, 23 (11), 1861-1868.
147. Stephensen, P. U.; Bonnesen, C.; Bjeldanes, L. F.; Vang, O. Modulation of cytochrome P4501A1 activity by ascorbigen in murine hepatoma cells. Biochem. Pharmacol., 1999, 58 (7), 1145-1153.
148. Wei, Y. D.; Helleberg, H.; Rannug, U.; Rannug, A. Rapid and transient induction of CYP1A1 gene expression in human cells by the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole. Chem. Biol. Interact., 1998, 110 (1-2), 39-55.
149. Bonnesen, C.; Eggleston, I. M.; Hayes, J. D. Dietary indoles and isothiocyanates that are generated from cruciferous vegetables can both stimulate apoptosis and confer protection against DNA damage in human colon cell lines. Cancer Res., 2001, 61 (16), 6120-6130.
150. Manson, M. M.; Hudson, E. A.; Ball, H. W.; Barrett, M. C.; Clark, H. L.; Judah, D. J.; Verschoyle, R. D.; Neal, G. E. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers. Carcinogenesis, 1998, 19 (10), 1829-1836.
151. Staack, R.; Wallig, M. A.; Jeffery, E. H.; Kingston, S. A comparison of the individual and collective effects of four glucosinolate breakdown products from Brussels sprouts on induction of detoxification enzymes. Toxicol. Appl. Pharmacol., 1998, 149 (1), 17-23.
152. Nho, C. W.; Jeffery, E. The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicol. Appl. Pharmacol., 2001, 174 (2), 146-152.
153. Baldwin, W. S.; LeBlanc, G. A. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice. Chem. Biol. Interact., 1992, 83 (2), 155-169.
154. Stephensen, P. U.; Bonnesen, C.; Schaldach, C.; Andersen, O.; Bjeldanes, L. F.; Vang, O. N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol. Nutr. Cancer, 2000, 36 (1), 112-121.
155. Vang, O.; Frandsen, H.; Hansen, K. T.; Nielsen, J. B.; Andersen, O. Modulation of drug-metabolising enzyme expression by condensation products of indole-3-ylcarbinol, an inducer in cruciferous vegetables. Pharmacol. Toxicol., 1999, 84 (2), 59-65.
156. Ociepa-Zawal, M.; Rubis, B.; Lacinski, M.; Trzeciak, W. H. The effect of indole-3-carbinol on the expression of CYP1A1, CYP1B1 and AhR genes and proliferation of MCF-7 cells. Acta Biochim. Pol., 2007, 54 (1), 113-117.
157. Reed, G. A.; Peterson, K. S.; Smith, H. J.; Gray, J. C.; Sullivan, D. K.; Mayo, M. S.; Crowell, J. A.; Hurwitz, A. A phase I study of indole- 3-carbinol in women: tolerability and effects. Cancer Epidemiol. Biomarkers Prev., 2005, 14 (8), 1953-1960.
158. Stresser, D. M.; Williams, D. E.; McLellan, L. I.; Harris, T. M.; Bailey, G. S. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exoepoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. Drug Metab. Dispos., 1994, 22 (3), 392-399.
159. Sanderson, J. T.; Slobbe, L.; Lansbergen, G. W.; Safe, S.; van den Berg, M. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. Toxicol. Sci., 2001, 61 (1), 40-48.
160. Wortelboer, H. M.; de Kruif, C. A.; van Iersel, A. A.; Falke, H. E.; Noordhoek, J.; Blaauboer, B. J. Acid reaction products of indole-3- carbinol and their effects on cytochrome P450 and phase II enzymes in rat and monkey hepatocytes. Biochem. Pharmacol., 1992, 43 (7), 1439-1447.
161. De Kruif, C. A.; Marsman, J. W.; Venekamp, J. C.; Falke, H. E.; Noordhoek, J.; Blaauboer, B. J.;Wortelboer, H. M. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem. Biol. Interact., 1991, 80 (3), 303-315.
162. Renwick, A. B.; Mistry, H.; Barton, P. T.; Mallet, F.; Price, R. J.; Beamand, J. A.; Lake, B. G. Effect of some indole derivatives on xenobiotic metabolism and xenobiotic-induced toxicity in cultured rat liver slices. Food Chem. Toxicol., 1999, 37 (6), 609-618.
163. Bradshaw, T. D.; Westwell, A. D. The development of the antitumour benzothiazole prodrug, phortress, as a clinical candidate. Curr. Med. Chem., 2004, 11 (8), 1009-1021.
164. Trapani, V.; Patel, V.; Leong, C. O.; Ciolino, H. P.; Yeh, G. C.; Hose, C.; Trepel, J. B.; Stevens, M. F.; Sausville, E. A.; Loaiza- Perez, A. I. DNA damage and cell cycle arrest induced by 2-(4- amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF- 7 cells. Br. J. Cancer, 2003, 88 (4), 599-605.
165. Grygiel, J. J.; Birkett, D. J. Cigarette smoking and theophylline clearance and metabolism. Clin. Pharmacol. Ther., 1981, 30 (4), 491-496.
166. Althuis, M. D.; Sexton, M.; Prybylski, D. Cigarette smoking and asthma symptom severity among adult asthmatics. J. Asthma, 1999, 36 (3), 257-264.
167. Patel, S. N.; Tsai, C. L.; Boudreaux, E. D.; Kilgannon, J. H.; Sullivan, A. F.; Blumenthal, D.; Camargo, C. A., Jr. Multicenter study of cigarette smoking among patients presenting to the emergency department with acute asthma. Ann. Allergy. Asthma. Immunol., 2009, 103 (2), 121-127.
168. Siroux, V.; Pin, I.; Oryszczyn, M. P.; Le Moual, N.; Kauffmann, F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur. Respir. J., 2000, 15 (3), 470-477.
169. Li, C. I.; Daling, J. R.; Malone, K. E. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J. Clin. Oncol., 2003, 21 (1), 28-34.
170. Krieger, N.; Chen, J. T.; Ware, J. H.; Kaddour, A. Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control, 2008, 19 (10), 1305-1318.
171. Sepkovic, D. W.; Bradlow, H. L. Estrogen hydroxylation--the good and the bad. Ann. N. Y. Acad. Sci., 2009, 1155 57-67.
172. Dawling, S.; Hachey, D. L.; Roodi, N.; Parl, F. F. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem. Res. Toxicol., 2004, 17 (9), 1258-1264.
173. Westerlind, K. C.; Gibson, K. J.; Malone, P.; Evans, G. L.; Turner, R. T. Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J. Bone Miner. Res., 1998, 13 (6), 1023-1031.
174. Lotinun, S.; Westerlind, K. C.; Turner, R. T. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alphahydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. J. Endocrinol., 2001, 170 (1), 165-174.
175. Westerlind, K. C.; Gibson, K. J.; Evans, G. L.; Turner, R. T. The catechol estrogen, 4-hydroxyestrone, has tissue-specific estrogen actions. J. Endocrinol., 2000, 167 (2), 281-287.
176. Bradlow, H. L.; Hershcopf, R. J.; Martucci, C. P.; Fishman, J. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans, Proc. Natl. Acad. Sci. USA, 1985, 82 (18), 6295-6299.
177. Schneider, J.; Kinne, D.; Fracchia, A.; Pierce, V.; Anderson, K. E.; Bradlow, H. L.; Fishman, J. Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. USA, 1982, 79 (9), 3047-3051.
178. Osborne, M. P.; Bradlow, H. L.; Wong, G. Y.; Telang, N. T. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Inst., 1993, 85 (23), 1917-1920.
179. Kabat, G. C.; O'Leary, E. S.; Gammon, M. D.; Sepkovic, D. W.; Teitelbaum, S. L.; Britton, J. A.; Terry, M. B.; Neugut, A. I.; Bradlow, H. L. Estrogen metabolism and breast cancer. Epidemiology, 2006, 17 (1), 80-88.
180. Kabat, G. C.; Chang, C. J.; Sparano, J. A.; Sepkovie, D. W.; Hu, X. P.; Khalil, A.; Rosenblatt, R.; Bradlow, H. L. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev., 1997, 6 (7), 505-509.
181. Ho, G. H.; Luo, X. W.; Ji, C. Y.; Foo, S. C.; Ng, E. H. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. Ann. Acad. Med. Singapore, 1998, 27 (2), 294-299.
182. Muti, P.; Bradlow, H. L.; Micheli, A.; Krogh, V.; Freudenheim, J. L.; Schunemann, H. J.; Stanulla, M.; Yang, J.; Sepkovic, D. W.; Trevisan, M.; Berrino, F. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology, 2000, 11 (6), 635-640.
183. Arslan, A. A.; Shore, R. E.; Afanasyeva, Y.; Koenig, K. L.; Toniolo, P.; Zeleniuch-Jacquotte, A. Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol. Biomarkers Prev., 2009, 18 (8), 2273-2279.
184. Ursin, G.; London, S.; Stanczyk, F. Z.; Gentzschein, E.; Paganini- Hill, A.; Ross, R. K.; Pike, M. C. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ. Health Perspect., 1997, 105 (Suppl 3), 601-605.
185. Riza, E.; dos Santos Silva, I.; De Stavola, B.; Bradlow, H. L.; Sepkovic, D. W.;Linos, D.;Linos, A. Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 2001, 10 (6), 627-634.
186. Wellejus, A.; Olsen, A.; Tjonneland, A.; Thomsen, B. L.; Overvad, K.; Loft, S. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Cancer Epidemiol. Biomarkers Prev., 2005, 14 (9), 2137-2142.
187. Fowke, J. H.; Qi, D.; Bradlow, H. L.; Shu, X. O.; Gao, Y. T.; Cheng, J. R.; Jin, F.; Zheng, W. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Steroids, 2003, 68 (1), 65-72.
188. Dong, W.; Wang, L.; Thornton, C.; Scheffler, B. E.; Willett, K. L. Benzo(a)pyrene decreases brain and ovarian aromatase mRNA expression in Fundulus heteroclitus. Aquat. Toxicol., 2008, 88 (4), 289-300.
189. Tong, S. K.; Chung, B. C. Analysis of zebrafish cyp19 promoters. J. Steroid Biochem. Mol. Biol., 2003, 86 (3-5), 381-386.
190. Cheshenko, K.; Brion, F.; Le Page, Y.; Hinfray, N.; Pakdel, F.; Kah, O.; Segner, H.; Eggen, R. I. Expression of zebra fish aromatase cyp19a and cyp19b genes in response to the ligands of estrogen receptor and aryl hydrocarbon receptor. Toxicol. Sci., 2007, 96 (2), 255-267.
191. Patel, M. R.; Scheffler, B. E.; Wang, L.; Willett, K. L. Effects of benzo(a)pyrene exposure on killifish (Fundulus heteroclitus) aromatase activities and mRNA. Aquat. Toxicol., 2006, 77 (3), 267-278.
192. Jablonska, O.; Shi, Z.; Valdez, K. E.; Ting, A. Y.; Petroff, B. K. Temporal and anatomical sensitivities to the aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin leading to premature acyclicity with age in rats. Int. J. Androl., 2010, 33 (2), 405-412.
193. Dasmahapatra, A. K.; Wimpee, B. A.; Trewin, A. L.; Wimpee, C. F.; Ghorai, J. K.; Hutz, R. J. Demonstration of 2,3,7,8- tetrachlorodibenzo-p-dioxin attenuation of P450 steroidogenic enzyme mRNAs in rat granulosa cell in vitro by competitive reverse transcriptase-polymerase chain reaction assay. Mol. Cell. Endocrinol., 2000, 164 (1-2), 5-18.
194. Huuskonen, P.; Storvik, M.; Reinisalo, M.; Honkakoski, P.; Rysa, J.; Hakkola, J.; Pasanen, M. Microarray analysis of the global alterations in the gene expression in the placentas from cigarettesmoking mothers. Clin. Pharmacol. Ther., 2008, 83 (4), 542-550.
195. Gierthy, J. F.; Lincoln Ii, D. W.; Kampcik, S. J.; Dickerman, H. W.; Bradlow, H. L.; Niwa, T.; Swaneck, G. E. Enhancement of 2- and 16α-estradiol hydroxylation in MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-P-dioxin. Biochem. Biophys. Res. Commun., 1988, 157 (2), 515-520.
196. Michnovicz, J. J.; Hershcopf, R. J.; Naganuma, H.; Bradlow, H. L.; Fishman, J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking, N. Engl. J. Med., 1986, 315 (21), 1305-1309.
197. Shimada, T.; Hiramatsu, N.; Hayakawa, K.; Takahashi, S.; Kasai, A.; Tagawa, Y.; Mukai, M.; Yao, J.; Fujii-Kuriyama, Y.; Kitamura, M. Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress. Am. J. Physiol. Endocrinol. Metab., 2009, 296 (4), E721-730.
198. Kitamura, M.; Kasai, A. Cigarette smoke as a trigger for the dioxin receptor-mediated signaling pathway. Cancer Lett., 2007, 252 (2), 184-194.
199. Reiter, E.; Reiter, E.; Beck, V.; Medjakovic, S.; Jungbauer, A. Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data. Gynecol. Endocrinol., 2009, 25 (9), 554-580.
200. Ye, L.; Chan, M. Y.; Leung, L. K. The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway. Mol. Cell. Endocrinol., 2009, 302 (1), 73-80.
201. Brooks, J. D.; Thompson, L. U. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid Biochem. Mol. Biol., 2005, 94 (5), 461-467.
202. Wang, Y.; Man Gho, W.; Chan, F. L.; Chen, S.; Leung, L. K. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br. J. Nutr., 2008, 99 (2), 303-310.
203. Rice, S.; Mason, H. D.; Whitehead, S. A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol., 2006, 101 (4-5), 216-225.
204. Pelissero, C.; Lenczowski, M. J.; Chinzi, D.; Davail-Cuisset, B.; Sumpter, J. P.; Fostier, A. Effects of flavonoids on aromatase activity, an in vitro study. J. Steroid Biochem. Mol. Biol., 1996, 57 (3- 4), 215-223.
205. Lacey, M.; Bohday, J.; Fonseka, S. M.; Ullah, A. I.; Whitehead, S. A. Dose-response effects of phytoestrogens on the activity and expression of 3beta-hydroxysteroid dehydrogenase and aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol., 2005, 96 (3-4), 279-286.
206. Whitehead, S. A.; Lacey, M. Phytoestrogens inhibit aromatase but not 17beta-hydroxysteroid dehydrogenase (HSD) type 1 in human granulosa-luteal cells: evidence for FSH induction of 17beta-HSD. Hum. Reprod., 2003, 18 (3), 487-494.
207. Edmunds, K. M.; Holloway, A. C.; Crankshaw, D. J.; Agarwal, S. K.; Foster, W. G. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reprod. Nutr. Dev., 2005, 45 (6), 709-720.
208. Le Bail, J. C.; Champavier, Y.; Chulia, A. J.; Habrioux, G. Effects of phytoestrogens on aromatase, 3beta and 17beta-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci., 2000, 66 (14), 1281-1291.
209. Kao, Y. C.; Zhou, C.; Sherman, M.; Laughton, C. A.; Chen, S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A sitedirected mutagenesis study. Environ. Health Perspect., 1998, 106 (2), 85-92.
210. Karkola, S.; Wähälä, K. The binding of lignans, flavonoids and coumestrol to CYP450 aromatase: a molecular modelling study. Mol. Cell. Endocrinol., 2009, 301 (1-2), 235-244.
211. Sarkar, S.; Jana, N. R.; Yonemoto, J.; Tohyama, C.; Sone, H. Estrogen enhances induction of cytochrome P-4501A1 by 2,3,7, 8- tetrachlorodibenzo-p-dioxin in liver of female Long-Evans rats. Int. J. Oncol., 2000, 16 (1), 141-147.
212. Ju, Y. H.; Doerge, D. R.; Woodling, K. A.; Hartman, J. A.; Kwak, J.; Helferich, W. G. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogendependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis, 2008, 29 (11), 2162-2168.
213. Allred, C. D.; Allred, K. F.; Ju, Y. H.; Goeppinger, T. S.; Doerge, D. R.; Helferich, W. G. Soy processing influences growth of estrogendependent breast cancer tumors. Carcinogenesis, 2004, 25 (9), 1649-1657.
214. Weber, K. S.; Jacobson, N. A.; Setchell, K. D.; Lephart, E. D. Brain aromatase and 5alpha-reductase, regulatory behaviors and testosterone levels in adult rats on phytoestrogen diets. Proc. Soc. Exp. Biol. Med., 1999, 221 (2), 131-135.
215. Weber, K. S.; Setchell, K. D.; Lephart, E. D. Maternal and perinatal brain aromatase: effects of dietary soy phytoestrogens. Brain Res. Dev. Brain Res., 2001, 126 (2), 217-221.
216. Lephart, E. D.; Adlercreutz, H.; Lund, T. D. Dietary soy phytoestrogen effects on brain structure and aromatase in Long-Evans rats. Neuroreport, 2001, 12 (16), 3451-3455.
217. Kishida, T.; Beppu, M.; Nashiki, K.; Izumi, T.; Ebihara, K. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2- hydroxyestrone ratio in C3H/HeJ mice. Nutr. Cancer, 2000, 38 (2), 209-214.
218. Fuhrman, B. J.; Pfeiffer, R.; Xu, X.; Wu, A. H.; Korde, L.; Gail, M. H.; Keefer, L. K.; Veenstra, T. D.; Hoover, R. N.; Ziegler, R. G. Soy intake is associated with increased 2-hydroxylation and decreased 16alpha-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol. Biomarkers Prev., 2009, 18 (10), 2751-2760.
219. Lu, L. J.; Cree, M.; Josyula, S.; Nagamani, M.; Grady, J. J.; Anderson, K. E. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones. Cancer Res., 2000, 60 (5), 1299-1305.
220. Xu, X.; Duncan, A. M.; Merz, B. E.; Kurzer, M. S. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol. Biomarkers Prev., 1998, 7 (12), 1101-1108.
221. Xu, X.; Duncan, A. M.; Wangen, K. E.; Kurzer, M. S. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 2000, 9 (8), 781-786.
222. Atkinson, C.; Skor, H. E.; Dawn F. E.; Scholes, D.; Chen, C.; Wahala, K.; Schwartz, S. M.; Lampe, J. W. Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women. J. Steroid Biochem. Mol. Biol., 2003, 86 (1), 71-77.
223. Parl, F. F.; Dawling, S.; Roodi, N.; Crooke, P. S. Estrogen metabolism and breast cancer: a risk model. Ann. N. Y. Acad. Sci., 2009, 1155 68-75.
224. Cavalieri, E.; Chakravarti, D.; Guttenplan, J.; Hart, E.; Ingle, J.; Jankowiak, R.; Muti, P.; Rogan, E.; Russo, J.; Santen, R.; Sutter, T. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta, 2006, 1766 (1), 63-78.
225. Mueck, A. O.; Seeger, H.; Lippert, T. H. Estradiol metabolism and malignant disease. Maturitas, 2002, 43 (1), 1-10.
226. Bolton, J. L.; Thatcher, G. R. Potential mechanisms of estrogen quinone carcinogenesis. Chem. Res. Toxicol., 2008, 21 (1), 93-101.
227. Cavalieri, E. L.; Stack, D. E.; Devanesan, P. D.; Todorovic, R.; Dwivedy, I.; Higginbotham, S.; Johansson, S. L.; Patil, K. D.; Gross, M. L.; Gooden, J. K.; Ramanathan, R.; Cerny, R. L.; Rogan, E. G. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 1997, 94 (20), 10937-10942.
228. Devanesan, P.; Todorovic, R.; Zhao, J.; Gross, M. L.; Rogan, E. G.; Cavalieri, E. L. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4- hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Carcinogenesis, 2001, 22 (3), 489-497.
229. Li, K. M.; Todorovic, R.; Devanesan, P.; Higginbotham, S.; Kofeler, H.; Ramanathan, R.; Gross, M. L.; Rogan, E. G.; Cavalieri, E. L. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis, 2004, 25 (2), 289-297.
230. Jankowiak, R.; Zamzow, D.; Stack, D. E.; Todorovic, R.; Cavalieri, E. L.; Small, G. J. Spectral characterization of fluorescently labeled catechol estrogen 3,4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue. Chem. Res. Toxicol., 1998, 11 (11), 1339-1345.
231. Markushin, Y.; Zhong, W.; Cavalieri, E. L.; Rogan, E. G.; Small, G. J.; Yeung, E. S.; Jankowiak, R. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Chem. Res. Toxicol., 2003, 16 (9), 1107-1117.
232. Zahid, M.; Kohli, E.; Saeed, M.; Rogan, E.; Cavalieri, E. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem. Res. Toxicol., 2006, 19 (1), 164-172.
233. Hayes, C. L.; Spink, D. C.; Spink, B. C.; Cao, J. Q.; Walker, N. J.; Sutter, T. R. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 1996, 93 (18), 9776-9781.
234. Cavalieri, E. L.; Devanesan, P.; Bosland, M. C.; Badawi, A. F.; Rogan, E. G. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis, 2002, 23 (2), 329-333.
235. Lehmann, L.; Jiang, L.; Wagner, J. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4- hydroxyestradiol in cultured MCF-7 cells. Carcinogenesis, 2008, 29 (2), 363-370.
236. Smith, S.; Sepkovic, D.; Bradlow, H. L.; Auborn, K. J. 3,3'- Diindolylmethane and genistein decrease the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells. J. Nutr., 2008, 138 (12), 2379-2385.
237. Low, Y. L.; Taylor, J. I.; Grace, P. B.; Dowsett, M.; Scollen, S.; Dunning, A. M.; Mulligan, A. A.; Welch, A. A.; Luben, R. N.; Khaw, K. T.; Day, N. E.; Wareham, N. J.; Bingham, S. A. Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol. Biomarkers Prev., 2005, 14 (1), 213-220.
238. Wang, Q.; Wang, Y. P.; Li, J. Y.; Yuan, P.; Yang, F.; Li, H. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study. Chin. J. Cancer, 2010, 29 (7), 683-688.
239. Telang, N. T.; Katdare, M.; Bradlow, H. L.; Osborne, M. P.; Fishman, J. Inhibition of proliferation and modulation of estradiol metabolism: novel mechanisms for breast cancer prevention by the phytochemical indole-3-carbinol. Proc. Soc. Exp. Biol. Med., 1997, 216 (2), 246-252.
240. Niwa, T.; Swaneck, G.; Bradlow, H. L. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3- carbinol and related compounds. Steroids, 1994, 59 (9), 523-527.
241. Kojima, T.; Tanaka, T.; Mori, H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3- carbinol. Cancer Res., 1994, 54 (6), 1446-1449.
242. Dalessandri, K. M.; Firestone, G. L.; Fitch, M. D.; Bradlow, H. L.; Bjeldanes, L. F. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr. Cancer, 2004, 50 (2), 161-167.
243. Michnovicz, J. J.; radlow, H. L. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol. Nutr. Cancer, 1991, 16 (1), 59-66.
244. Michnovicz, J. J. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int. J. Obes. Relat. Metab. Disord., 1998, 22 (3), 227-229.
245. Michnovicz, J. J.; Adlercreutz, H.; Bradlow, H. L. Changes in levels of urinary estrogen metabolites after oral indole-3- carbinol treatment in humans. J. Natl. Cancer Inst., 1997, 89 (10), 718-723.
246. Parkin, D. R.; Lu, Y.; Bliss, R. L.; Malejka-Giganti, D. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYPcatalyzed reactions in female rats. Food Chem. Toxicol., 2008, 46 (7), 2451-2458.
247. Carlson, D. B.; Perdew, G. H. A dynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. J. Biochem. Mol. Toxicol., 2002, 16 (6), 317-325.
248. Elferink, C. J. Aryl hydrocarbon receptor-mediated cell cycle control. Prog. Cell Cycle Res., 2003, 5 261-267.
249. Marlowe, J. L.; Puga, A. Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis. J. Cell. Biochem., 2005, 96 (6), 1174-1184.
250. Nebert, D. W.; Roe, A. L.; Dieter, M. Z.; Solis, W. A.; Yang, Y.; Dalton, T. P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol., 2000, 59 (1), 65-85.
251. Jung, N. K.; Park, J. Y.; Park, J. H.; Kim, S. Y.; Park, J. K.; Chang, W. K.; Lee, H. C.; Kim, S. W.; Chun, S. Y. Attenuation of cell cycle progression by 2,3,7,8-tetrachlorodibenzo-p-dioxin eliciting ovulatory blockade in gonadotropin-primed immature rats. Endocr. J., 2010, 57 (10), 863-871.
252. Barhoover, M. A.; Hall, J. M.; Greenlee, W. F.; Thomas, R. S. Aryl hydrocarbon receptor regulates cell cycle progression in human breast cancer cells via a functional interaction with cyclindependent kinase 4. Mol. Pharmacol., 2010, 77 (2), 195-201.
253. Elizondo, G.; Fernandez-Salguero, P.; Sheikh, M. S.; Kim, G. Y.; Fornace, A. J.; Lee, K. S.; Gonzalez, F. J. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol. Pharmacol., 2000, 57 (5), 1056-1063.
254. Jeffy, B. D.; Chen, E. J.; Gudas, J. M.; Romagnolo, D. F. Disruption of cell cycle kinetics by benzo[a]pyrene: inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. Neoplasia, 2000, 2 (5), 460-470.
255. Ray, S. S.; Swanson, H. I. Dioxin-induced immortalization of normal human keratinocytes and silencing of p53 and p16INK4a. J. Biol. Chem., 2004, 279 (26), 27187-27193.
256. Zhang, L.; Wu, R.; Dingle, R. W.; Gairola, C. G.; Valentino, J.; Swanson, H. I. Cigarette smoke condensate and dioxin suppress culture shock induced senescence in normal human oral keratinocytes. Oral Oncol., 2007, 43 (7), 693-700.
257. Jin, D. Q.; Jung, J. W.; Lee, Y. S.; Kim, J. A. 2,3,7,8- Tetrachlorodibenzo-p-dioxin inhibits cell proliferation through arylhydrocarbon receptor-mediated G1 arrest in SK-N-SH human neuronal cells. Neurosci. Lett., 2004, 363 (1), 69-72.
258. Vaziri, C.; Faller, D. V. A benzo[a]pyrene-induced cell cycle checkpoint resulting in p53-independent G1 arrest in 3T3 fibroblasts. J. Biol. Chem., 1997, 272 (5), 2762-2769.
259. Strobeck, M. W.; Fribourg, A. F.; Puga, A.; Knudsen, E. S. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene, 2000, 19 (15), 1857-1867.
260. Schreck, I.; Chudziak, D.; Schneider, S.; Seidel, A.; Platt, K. L.; Oesch, F.; Weiss, C. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells. Toxicology, 2009, 259 (3), 91-96.
261. Mathieu, M. C.; Lapierre, I.; Brault, K.; Raymond, M. Aromatic hydrocarbon receptor (AhR).AhR nuclear translocator- and p53- mediated induction of the murine multidrug resistance mdr1 gene by 3-methylcholanthrene and benzo(a)pyrene in hepatoma cells. J. Biol. Chem., 2001, 276 (7), 4819-4827.
262. Ge, N. L.; Elferink, C. J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein: Linking dioxin signaling to the cell cycle. J. Biol. Chem., 1998, 273 (35), 22708-22713.
263. Weinberg, R. A. The retinoblastoma protein and cell cycle control, Cell, 1995, 81 (3), 323-330.
264. Puga, A.; Barnes, S. J.; Dalton, T. P.; Chang, C.; Knudsen, E. S.; Maier, M. A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem., 2000, 275 (4), 2943-2950.
265. Elferink, C. J.; Ge, N. L.; Levine, A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol. Pharmacol., 2001, 59 (4), 664-673.
266. Ganguly, A.; Shields, C. L. Differential gene expression profile of retinoblastoma compared to normal retina. Mol. Vis., 2010, 16 1292-1303.
267. Marlowe, J. L.; Knudsen, E. S.; Schwemberger, S.; Puga, A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J. Biol. Chem., 2004, 279 (28), 29013-29022.
268. Ait-Si-Ali, S.; Polesskaya, A.; Filleur, S.; Ferreira, R.; Duquet, A.; Robin, P.; Vervish, A.; Trouche, D.; Cabon, F.; Harel-Bellan, A. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene, 2000, 19 (20), 2430-2437.
269. Marlowe, J. L.; Fan, Y.; Chang, X.; Peng, L.; Knudsen, E. S.; Xia, Y.; Puga, A. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol. Biol. Cell, 2008, 19 (8), 3263-3271.
270. Watabe, Y.; Nazuka, N.; Tezuka, M.; Shimba, S. Aryl hydrocarbon receptor functions as a potent coactivator of E2F1-dependent trascription activity. Biol. Pharm. Bull., 2010, 33 (3), 389-397.
271. Polager, S.; Ginsberg, D. p53 and E2f: partners in life and death. Nat. Rev. Cancer, 2009, 9 (10), 738-748.
272. Wang, B. F.; Wang, J. S.; Lu, J. F.; Kao, T. H.; Chen, B. H. Antiproliferation effect and mechanism of prostate cancer cell lines as affected by isoflavones from soybean cake. J. Agric. Food Chem., 2009, 57 (6), 2221-2232.
273. Raffoul, J. J.; Wang, Y.; Kucuk, O.; Forman, J. D.; Sarkar, F. H.; Hillman, G. G. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer, 2006, 6, 107.
274. Cappelletti, V.; Fioravanti, L.; Miodini, P.; Di Fronzo, G. Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J. Cell. Biochem., 2000, 79 (4), 594-600.
275. Casagrande, F.; Darbon, J. M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem. Pharmacol., 2001, 61 (10), 1205-1215.
276. Darbon, J. M.; Penary, M.; Escalas, N.; Casagrande, F.; Goubin- Gramatica, F.; Baudouin, C.; Ducommun, B. Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J. Biol. Chem., 2000, 275 (20), 15363-15369.
277. Su, S. J.; Yeh, T. M.; Lei, H. Y.; Chow, N. H. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin. Cancer Res., 2000, 6 (1), 230-236.
278. Casagrande, F.; Darbon, J. M. p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell Res., 2000, 258 (1), 101-108.
279. Chang, K. L.; Kung, M. L.; Chow, N. H.; Su, S. J. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem. Pharmacol., 2004, 67 (4), 717-726.
280. Frey, R. S.; Li, J.; Singletary, K. W. Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and Cdc25C expression. Biochem. Pharmacol., 2001, 61 (8), 979-989.
281. Majid, S.; Kikuno, N.; Nelles, J.; Noonan, E.; Tanaka, Y.; Kawamoto, K.; Hirata, H.; Li, L. C.; Zhao, H.; Okino, S. T.; Place, R. F.; Pookot, D.; Dahiya, R. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res., 2008, 68 (8), 2736-2744.
282. Sanchez, Y.; Amran, D.; de Blas, E.; Aller, P. Regulation of genistein- induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation. Biochem. Pharmacol., 2009, 77 (3), 384-396.
283. Shen, J. C.; Klein, R. D.; Wei, Q.; Guan, Y.; Contois, J. H.; Wang, T. T.; Chang, S.; Hursting, S. D. Low-dose genistein induces cyclin- dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells. Mol. Carcinog., 2000, 29 (2), 92-102.
284. Rahal, O. M.; Simmen, R. C. PTEN and p53 cross-regulation induced by soy isoflavone genistein promotes mammary epithelial cell cycle arrest and lobuloalveolar differentiation. Carcinogenesis, 2010, 31 (8), 1491-1500.
285. Ouyang, G.; Yao, L.; Ruan, K.; Song, G.; Mao, Y.; Bao, S. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways. Cell Biol. Int., 2009, 33 (12), 1237-1244.
286. Zhao, R.; Xiang, N.; Domann, F. E.; Zhong, W. Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr. Cancer, 2009, 61 (3), 397-407.
287. Katz, J.; Blake, E.; Medrano, T. A.; Sun, Y.; Shiverick, K. T. Isoflavones and gamma irradiation inhibit cell growth in human salivary gland cells. Cancer Lett., 2008, 270 (1), 87-94.
288. Schmidt, F.; Knobbe, C. B.; Frank, B.; Wolburg, H.; Weller, M. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines. Oncol. Rep., 2008, 19 (4), 1061-1066.
289. Ismail, I. A.; Kang, K. S.; Lee, H. A.; Kim, J. W.; Sohn, Y. K. Genistein-induced neuronal apoptosis and G2/M cell cycle arrest is associated with MDC1 up-regulation and PLK1 down-regulation. Eur. J. Pharmacol., 2007, 575 (1-3), 12-20.
290. Dijsselbloem, N.; Goriely, S.; Albarani, V.; Gerlo, S.; Francoz, S.; Marine, J. C.; Goldman, M. Haegeman, G.; Vanden Berghe, W. A critical role for p53 in the control of NF-kappaB-dependent gene expression in TLR4-stimulated dendritic cells exposed to Genistein. J. Immunol., 2007, 178 (8), 5048-5057.
291. Pinski, J.; Wang, Q.; Quek, M. L.; Cole, A.; Cooc, J.; Danenberg, K.; Danenberg, P. V. Genistein-induced neuroendocrine differentiation of prostate cancer cells. Prostate, 2006, 66 (11), 1136-1143.
292. Bemis, D. L.; Capodice, J. L.; Desai, M.; Buttyan, R.; Katz, A. E. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin. Cancer Res., 2004, 10 (15), 5282-5292.
293. Naik, R.; Nixon, S.; Lopes, A.; Godfrey, K.; Hatem, M. H.; Monaghan, J. M. A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia. Int. J. Gynecol. Cancer, 2006, 16 (2), 786-790.
294. Wong, G. Y.; Bradlow, L.; Sepkovic, D.; Mehl, S.; Mailman, J.; Osborne, M. P. Dose-ranging study of indole-3-carbinol for breast cancer prevention. J. Cell. Biochem. Suppl., 1997, 28-29, 111-116.
295. Weng, J. R.; Bai, L. Y.; Omar, H. A.; Sargeant, A. M.; Yeh, C. T.; Chen, Y. Y.; Tsai, M. H.; Chiu, C. F. A novel indole-3-carbinol derivative inhibits the growth of human oral squamous cell carcinoma in vitro. Oral Oncol., 2010, 46 (10), 748-754.
296. Xu, Y.; Zhang, J.; Dong, W. G. Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway. Med. Oncol., 2010 [Epub ahead of print].
297. Kassie, F.; Melkamu, T.; Endalew, A.; Upadhyaya, P.; Luo, X.; Hecht, S. S. Inhibition of lung carcinogenesis and critical cancerrelated signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)- l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination. Carcinogenesis, 2010, 31 (9), 1634-1641.
298. Choi, H. S.; Cho, M. C.; Lee, H. G.; Yoon, D. Y. Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells. Food Chem. Toxicol., 2010, 48 (3), 883-890.
299. Kronbak, R.; Duus, F.; Vang, O. Effect of 4-methoxyindole-3-carbinol on the proliferation of colon cancer cells in vitro, when treated alone or in combination with indole-3-carbino. J. Agric. Food Chem., 2010, 58 (14), 8453-8459.
300. Nakamura, Y.; Yogosawa, S.; Izutani, Y.; Watanabe, H.; Otsuji, E.; Sakai, T. A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol. Cancer, 2009, 8, 100.
301. Kim, Y. H.; Kwon, H. S.; Kim, D. H.; Shin, E. K.; Kang, Y. H.; Park, J. H.; Shin, H. K.; Kim, J. K. 3,3'-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm. Bowel Dis., 2009, 15 (8), 1164-1173.
302. Wu, Y.; Feng, X.; Jin, Y.; Wu, Z.; Hankey, W.; Paisie, C.; Li, L.; Liu, F.; Barsky, S. H.; Zhang, W.; Ganju, R.; Zou, X. A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation. Cancer Prev. Res. (Phila), 2010, 3 (7), 818-828.
303. Nguyen, H. H.; Lavrenov, S. N.; Sundar, S. N.; Nguyen, D. H.; Tseng, M.; Marconett, C. N.; Kung, J.; Staub, R. E.; Preobrazhenskaya, M. N.; Bjeldanes, L. F.; Firestone, G. L. 1-Benzyl-indole-3- carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells. Chem. Biol. Interact., 2010, 186 (3), 255-266.
304. Cover, C. M.; Hsieh, S. J.; Cram, E. J.; Firestone, G. L.; Hong, C.; Riby, J. E.; Bjeldanes, L. F. Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. Cancer Res., 1999, 59 (6), 1244-1251.
305. Brandi, G.; Paiardini, M.; Cervasi, B.; Fiorucci, C.; Filippone, P.; De Marco, C.; Zaffaroni, N.; Magnani, M. A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression, and induces G1 cell cycle arrest in both estrogen-dependent and estrogen- independent breast cancer cell lines. Cancer Res., 2003, 63 (14), 4028-4036.
306. Cover, C. M.; Hsieh, S. J.; Tran, S. H.; Hallden, G.; Kim, G. S.; Firestone, G. L.; Bjeldanes, L. F. Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J. Biol. Chem., 1998, 273 (7), 3838-3847.
307. Chang, X.; Tou, J. C.; Hong, C.; Kim, H. A.; Riby, J. E.; Firestone, G. L.; Bjeldanes, L. F. 3,3'-diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis, 2005, 26 (4), 771-778.
308. Sarkar, F. H.; Rahman, K. M. W.; Li, Y. Bax translocation to mitochondria is an important event in inducing apoptotic cell death by indole-3-carbinol (I3C) treatment of breast cancer cells. J. Nutr., 2003, 133 (7 Suppl.), 2434S-2439S.
309. Rahman, K. M.; Aranha, O.; Sarkar, F. H. Indole-3-carbinol (I3C) induces apoptosis in tumorigenic but not in nontumorigenic breast epithelial cells. Nutr. Cancer, 2003, 45 (1), 101-112.
310. Firestone, G. L.; Bjeldanes, L. F. Indole-3-carbinol and 3-3'- diindolylmethane antiproliferative signaling pathways control cell cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J. Nutr., 2003, 133 (7 Suppl), 2448S-2455S.
311. Sarkar, F. H.; Li, Y. Indole-3-carbinol and prostate cancer. J. Nutr., 2004, 134 (12 SUPPL.).
312. Garikapaty, V. P.; Ashok, B. T.; Tadi, K.; Mittelman, A.; Tiwari, R. K. Synthetic dimer of indole-3-carbinol: Second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. Prostate, 2006, 66 (5), 453-462.
313. Garikapaty, V. P. S.; Ashok, B. T.; Tadi, K.; Mittelman, A.; Tiwari, R. K. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochem. Biophys. Res. Commun., 2006, 340 (2), 718-725.
314. Zhang, J.; Hsu, J. C.; Kinseth, M. A.; Bjeldanes, L. F.; Firestone, G. L. Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer, 2003, 98 (11), 2511-2520.
315. Chinnakannu, K.; Chen, D.; Li, Y.; Wang, Z.; Dou, Q. P.; Reddy, G. P.; Sarkar, F. H. Cell cycle-dependent effects of 3,3'- diindolylmethane on proliferation and apoptosis of prostate cancer cells. J. Cell. Physiol., 2009, 219 (1), 94-99.
316. Nachshon-Kedmi, M.; Yannai, S.; Fares, F. A. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'- diindolylmethane through the mitochondrial pathway. Br. J. Cancer, 2004, 91 (7), 1358-1363.
317. Nachshon-Kedmi, M.; Fares, F. A.; Yannai, S. Therapeutic activity of 3,3'-diindolylmethane on prostate cancer in an in vivo model. Prostate, 2004, 61 (2), 153-160.
318. Nachshon-Kedmi, M.; Yannai, S.; Haj, A.; Fares, F. A. Indole-3- carbinol and 3,3'-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem. Toxicol., 2003, 41 (6), 745-752.
319. Hsu, J. C.; Dev, A.; Wing, A.; Brew, C. T.; Bjeldanes, L. F.; Firestone, G. L. Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem. Pharmacol., 2006, 72 (12), 1714-1723.
320. Vivar, O. I.; Lin, C. L.; Firestone, G. L.; Bjeldanes, L. F. 3,3'- Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochem. Pharmacol., 2009, 78 (5), 469-476.
321. Tadi, K.; Chang, Y.; Ashok, B. T.; Chen, Y.; Moscatello, A.; Schaefer, S. D.; Schantz, S. P.; Policastro, A. J.; Geliebter, J.; Tiwari, R. K. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease. Biochem. Biophys. Res. Commun., 2005, 337 (3), 1019-1025.
322. Hong, C.; Kim, H. A.; Firestone, G. L.; Bjeldanes, L. F. 3,3'- Diindolymethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression. Carcinogenesis, 2002, 23 (8), 1297-1305.
323. Suzui, M.; Inamine, M.; Kaneshiro, T.; Morioka, T. Yoshimi, N.; Suzuki, R.; Kohno, H.; Tanaka, T. Indole-3-carbinol inhibits the growth of human colon carcinoma cells but enhances the tumor multiplicity and volume of azoxymethane-induced rat colon carcinogenesis. Int. J. Oncol., 2005, 27 (5), 1391-1399.
324. Ebert, B.; Seidel, A.; Lampen, A. Induction of phase-1 metabolizing enzymes by oltipraz, flavone and indole-3-carbinol enhance the formation and transport of benzo[a]pyrene sulfate conjugates in intestinal Caco-2 cells. Toxicol. Lett., 2005, 158 (2), 140-151.
325. de Waard, P. W.; de Kok, T. M.; Maas, L. M.; Peijnenburg, A. A.; Hoogenboom, R. L.; Aarts, J. M.; van Schooten, F. J. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. Mutagenesis, 2008, 23 (1), 67-73.
326. de Waard, W. J.; Aarts, J. M.; Peijnenburg, A. A.; Baykus, H.; Talsma, E.; Punt, A.; de Kok, T. M.; van Schooten, F. J.; Hoogenboom, L. A. Gene expression profiling in Caco-2 human colon cells exposed to TCDD, benzo[a]pyrene, and natural Ah receptor agonists from cruciferous vegetables and citrus fruits. Toxicol. In Vitro, 2008, 22 (2), 396-410.
327. Pohjanvirta, R.; Korkalainen, M.; McGuire, J.; Simanainen, U.; Juvonen, R.; Tuomisto, J. T.; Unkila, M.; Viluksela, M.; Bergman, J.; Poellinger, L.; Tuomisto, J. Comparison of acute toxicities of indolo[3,2-b]carbazole (ICZ) and 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) in TCDD-sensitive rats. Food Chem. Toxicol., 2002, 40 (7), 1023-1032.
328. Okino, S. T.; Pookot, D.; Basak, S.; Dahiya, R. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention. Cancer Prev. Res. (Phila), 2009, 2 (3), 251-256.
329. Knockaert, M.; Blondel, M.; Bach, S.; Leost, M.; Elbi, C.; Hager, G. L.; Nagy, S. R.; Han, D.; Denison, M.; Ffrench, M.; Ryan, X. P.; Magiatis, P.; Polychronopoulos, P.; Greengard, P.; Skaltsounis, L.; Meijer, L. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene, 2004, 23 (25), 4400-4412.
330. Prochazkova, J.; Kozubik, A.; Machala, M.; Vondracek, J. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells. Toxicology, 2011, 279 ((1-3)), 146-154.
331. Adachi, J.; Mori, Y.; Matsui, S.; Matsuda, T. Comparison of gene expression patterns between 2,37,8-tetrachlorodibenzo-p-dioxin and a natural arylhydrocarbon receptor ligand, indirubin. Toxicol. Sci., 2004, 80 (1), 161-169.
332. Kim, S. H.; Henry, E. C.; Kim, D. K.; Kim, Y. H.; Shin, K. J.; Han, M. S.; Lee, T. G.; Kang, J. K.; Gasiewicz, T. A.; Ryu, S. H.; Suh, P. G. Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2- methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8- TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol. Pharmacol., 2006, 69 (6), 1871-1878.
333. Zhao, B.; Degroot, D. E.; Hayashi, A.; He, G.; Denison, M. S. CH223191 is a ligand-selective antagonist of the Ah (Dioxin) receptor. Toxicol. Sci., 2010, 117 (2), 393-403.
334. Dolinoy, D. C.; Huang, D.; Jirtle, R. L. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development, Proc. Natl. Acad. Sci. USA, 2007, 104 (32), 13056-13061.
335. Dolinoy, D. C.; Weidman, J. R.; Waterland, R. A.; Jirtle, R. L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect., 2006, 114 (4), 567-572.
336. U. S. National Institute of Health. http://clinicaltrials.gov/ (Accessed October 29, 2010).